PPARA and metabolic dysfunction-associated steatotic liver disease: The aim of this study was to characterize the expression of principle genes encoding enzymes involved in fatty acid metabolism (MnSOD2, PPAR-α and PPAR-γ) in a rat model of NAFLD and record the changes in their levels following administration of either rosiglitazone or bezafibrate.